FDA Inspection 1316082 - Aurobindo Pharma USA Inc - June 04, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Aurobindo Pharma USA Inc

Record Details

This FDA Inspection record concerns Aurobindo Pharma USA Inc, with an inspection on June 4, 2026, issued by the New Jersey District Office, covering human drugs.

Company: Aurobindo Pharma USA Inc
Inspection Date: June 4, 2026
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · a13953a3-edc8-48d1-8c73-d267408050dd